222 related articles for article (PubMed ID: 23110075)
1. Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
Bond CE; Umapathy A; Buttenshaw RL; Wockner L; Leggett BA; Whitehall VL
PLoS One; 2012; 7(10):e47483. PubMed ID: 23110075
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability.
Bond CE; Nancarrow DJ; Wockner LF; Wallace L; Montgomery GW; Leggett BA; Whitehall VL
PLoS One; 2014; 9(3):e91739. PubMed ID: 24651849
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability.
Kakar S; Deng G; Sahai V; Matsuzaki K; Tanaka H; Miura S; Kim YS
Arch Pathol Lab Med; 2008 Jun; 132(6):958-64. PubMed ID: 18517279
[TBL] [Abstract][Full Text] [Related]
5. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
[TBL] [Abstract][Full Text] [Related]
7. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
[TBL] [Abstract][Full Text] [Related]
8. A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers.
Silver A; Sengupta N; Propper D; Wilson P; Hagemann T; Patel A; Parker A; Ghosh A; Feakins R; Dorudi S; Suraweera N
Int J Cancer; 2012 Mar; 130(5):1082-92. PubMed ID: 21455990
[TBL] [Abstract][Full Text] [Related]
9. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
[TBL] [Abstract][Full Text] [Related]
10. BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer.
Chen KH; Lin YL; Liau JY; Tsai JH; Tseng LH; Lin LI; Liang JT; Lin BR; Hung JS; Chang YL; Yeh KH; Cheng AL
Med Oncol; 2016 May; 33(5):39. PubMed ID: 27034263
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.
Lochhead P; Kuchiba A; Imamura Y; Liao X; Yamauchi M; Nishihara R; Qian ZR; Morikawa T; Shen J; Meyerhardt JA; Fuchs CS; Ogino S
J Natl Cancer Inst; 2013 Aug; 105(15):1151-6. PubMed ID: 23878352
[TBL] [Abstract][Full Text] [Related]
13. DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy.
Fadhil W; Kindle K; Jackson D; Zaitoun A; Lane N; Robins A; Ilyas M
Int J Exp Pathol; 2014 Feb; 95(1):16-23. PubMed ID: 24456329
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.
Cai G; Xu Y; Lu H; Shi Y; Lian P; Peng J; Du X; Zhou X; Guan Z; Shi D; Cai S
Int J Colorectal Dis; 2008 Apr; 23(4):365-73. PubMed ID: 18193434
[TBL] [Abstract][Full Text] [Related]
16. Refining molecular analysis in the pathways of colorectal carcinogenesis.
Rowan A; Halford S; Gaasenbeek M; Kemp Z; Sieber O; Volikos E; Douglas E; Fiegler H; Carter N; Talbot I; Silver A; Tomlinson I
Clin Gastroenterol Hepatol; 2005 Nov; 3(11):1115-23. PubMed ID: 16271343
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
[TBL] [Abstract][Full Text] [Related]
18. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
[TBL] [Abstract][Full Text] [Related]
19. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A
Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
[TBL] [Abstract][Full Text] [Related]
20. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
